24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Epitomee
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
13:31
“To get Israel to a more precise position in biotech, we need to educate our people to become better managers”
11:51
Could Prompt Security be SentinelOne’s lifeline as shares slide 35% this year?
11:21
“Combined with AI and classical computing, quantum computing is the most influential and dangerous tool we’ve ever had”
10:51
Women, work, and menopause: Navigating income, expenses, and career transitions
More stories
Buzz
Most popular
Daily
Weekly
1
“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals
2
Nice puts Actimize up for sale at a $1.5-2 billion price tag
3
Johny Srouji weighs leaving Apple, raising stakes for the Israeli executive who built its silicon program
4
Zafran raises $60 million and doubles valuation as it chooses independence over takeover offers
5
Israeli drone startup Heven hits $1 billion valuation in $100 million round led by IonQ
More news
Epitomee
4 stories about Epitomee
Epitomee surges 200% in two days on FDA approval for weight loss pill
16.09.24
|
Adiel Eithan Mustaki
Investors are hopeful, but the company must now face an uphill battle in a crowded market.
Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement
04.12.23
|
Adiel Eithan Mustaki
The Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level
Weight loss pill success sparks stock surge at Epitomee Medical
04.09.23
|
Adiel Eithan Mustaki
The company, which has not yet published the full results of its study, plans to seek FDA approval via the 510(k) pathway
Weight-Loss Pill Developer Epitomee Raises $8 Million
10.04.19
|
CTech
Epitomee develops an orally administered capsule that affects the stomach through mechanosensory stimulation, encouraging prolonged gastric emptying and giving patients the sensation of being full